Category: Health

Pacritinib Study Enrolls Adults and Adolescents With MDS and MDS/MPN

A registry record describes a study of oral pacritinib in people aged 12 and older with MDS or MDS/MPN, with treatment potentially continuing for up to eight years.

Read More

Follow Us

Advertisements